남미의 의약품용 블리스터 포장 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the South America pharmaceutical blister packaging market size was valued at USD 1.18 billion in 2025 and is estimated to expand from USD 1.26 billion in 2026 to reach USD 1.72 billion by 2031, at a CAGR of 6.42% during the forecast period (2026-2031).

South America Pharmaceutical Blister Packaging Market Trends and Insights

Rising Unit-Dose and Adherence Packaging Demand

Unit-dose blisters support medication safety, dispensing accuracy, and clearer records across the pharmaceutical supply chain. An aging population is expected to increase polypharmacy, which strengthens the need for packs that separate doses and make treatment schedules easier to follow. Hospital pharmacy automation also favors consistent cavity dimensions that work with unit-dose dispensing systems. Once hospitals install cassette-based automation, changing to another primary format can require additional equipment spending and workflow changes. Argentina's Disposicion 8277 requires individually identifiable, peelable unit-dose blisters for oral solid medicines supplied to hospitals. These requirements are shaping specifications in retail settings as pharmacies align institutional and community dispensing practices This matters because packaging decisions must fit established pharmaceutical quality procedures, production schedules, and distribution practices across the region.

Pharmaceutical Serialization and Traceability Requirements

Serialization is making compliant printing and verification capacity more important across the South America pharmaceutical blister packaging market. Argentina's Disposicion 3294/2025 requires QR or Data Matrix codes on secondary pharmaceutical packaging. The requirement applies to pharmaceutical specialties and supports patient access to product information. Packaging converters increasingly need validated code printing and vision inspection systems before they can serve regulated pharmaceutical customers. This capability can influence contract awards because a supplier without verified production records may not meet customer qualification requirements. The resulting investment cycle extends to generic manufacturers and contract producers that are upgrading lines for regulated supply arrangements The requirement also affects how manufacturers coordinate material qualification, line operation, product release, and pharmacy supply activities.

Medical-Waste and Difficult-to-Recycle Multilayer Structures

Multilayer blisters commonly combine PVC, PVDC, and aluminum, which makes conventional mechanical recycling difficult. Chile and Colombia have introduced packaging recovery and recycled-content requirements that add compliance work for converters using these structures. Recyclable mono-material alternatives can reduce this issue, but pharmaceutical companies must first confirm that new packs protect medicines under required storage conditions. Klockner Pentaplast offers recyclable rigid film solutions for pharmaceutical applications, illustrating the material direction available to manufacturers. Validation can take 12-24 months, which slows immediate replacement of established multilayer packs. The South America pharmaceutical blister packaging market will therefore see a gradual change rather than a rapid shift away from traditional structures The issue links material selection with operating reliability, documented quality controls, and the everyday requirements of medicine distribution.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Generic-Drug and Contract-Manufacturing Capacity
2. High-Barrier Protection for Moisture-Sensitive Medicines
3. PVC, Aluminum, Resin, and Currency Volatility

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Carded and face-seal blisters held 25.83% of the 2025 product-type share, making them the largest product category in the South America pharmaceutical blister packaging market. Their position reflects their established use for solid oral medicines sold through retail pharmacies and hospital distribution channels. The format works with common thermoforming equipment and suits high-volume generic-drug programs. It also allows pharmaceutical companies to standardize pack presentation across different tablet products. Clamshell blisters remain relevant for diagnostic kits and over-the-counter products that need physical product visibility or added protection This matters because packaging decisions must fit established pharmaceutical quality procedures, production schedules, and distribution practices across the region, and the category also remains useful for manufacturers that need a familiar pack configuration across multiple medicines and distribution settings, while keeping production planning aligned with established equipment and operator training.

Child-resistant and senior-friendly blisters are projected to expand at a 7.82% CAGR through 2031. This category addresses the need to prevent unintended access by children while allowing older patients to open prescribed medicines. It requires careful lidding selection and pack design because both objectives must be met in the same format. Trapped and full-card structures provide further tamper-evidence options for premium branded products. The South America pharmaceutical blister packaging industry is responding with designs that support safety, accessibility, and clear product identification The requirement also affects how manufacturers coordinate material qualification, line operation, product release, and pharmacy supply activities, creating a need for suppliers to work closely with pharmaceutical teams on opening performance, pack information, child protection expectations, and the practical needs of patients who manage recurring medicine schedules.

Plastic films held 40.71% of the 2025 material share, supported by the wide use of thermoforming-grade PVC for solid oral medicines. PVC offers a familiar balance of cost, processing performance, and moderate moisture resistance for many established products. Aluminum foil remains essential as a lidding substrate and as a forming web in cold-form packs. Its demand is linked to the need for barrier protection in moisture-sensitive medicine categories. Specialty films such as PCTFE, COC, and aclar-based materials serve biologic and oncology applications where barrier requirements limit material substitution Its practical effect depends on whether the supplier can meet the customer's stated specification without disrupting routine production planning, while material decisions also require attention to forming behavior, seal integrity, printing, supply availability, and the full set of product requirements that apply before a commercial medicine pack is released.

Paper and paperboard is expected to expand at a 7.51% CAGR through 2031 as pharmaceutical companies seek to reduce plastic content. Chilean and Colombian packaging requirements are strengthening the business case for structures that fit emerging recovery systems. The South America pharmaceutical blister packaging market size for paper and paperboard is projected to expand at a 7.51% CAGR through 2031. Constantia Flexibles presented PERPETUA and REGULA CIRC as pharmaceutical packaging approaches that focus on recyclable or PVC-free structures. Adoption will remain dependent on proving drug stability and manufacturability under regional regulatory expectations. The material shift is therefore likely to proceed product by product rather than through a uniform replacement of PVC This consideration is especially relevant where medicine producers manage broad product portfolios with different protection and dispensing needs, and the change favors providers that can explain how each option works in regional storage conditions and on available equipment, rather than offering barrier performance as a separate technical feature.

Complete Report Scope:

• By Product Type
  • Carded and Face-Seal Blisters
  • Clamshell Blisters
  • Trapped and Full-Card Blisters
  • Child-Resistant and Senior-Friendly Blisters
  • Other Product Types
• By Material
  • Plastic Films
  • Aluminum Foil
  • Paper and Paperboard
  • Other Materials
• By Technology
  • Thermoforming
  • Cold Forming
  • Heat-Seal and Heat-Shrink
• By Application
  • Tablets
  • Capsules
  • Oral Thin Films and Lozenges
  • Diagnostic Kits
  • Other Applications
• By End User
  • Branded and Generic Pharmaceutical Manufacturers
  • Contract Development and Manufacturing Organizations
  • Contract Packaging Organizations
• By Packaging Format
  • Push-Through Blisters
  • Peelable Blisters
  • Alu-Alu Blisters
  • PVC-PVDC Blisters
  • PVC-PET and Polypropylene Blisters
• By Geography
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America

List of Companies Covered in this Report:

1. Constantia Flexibles Group GmbH
2. Tekni-Plex, Inc.
3. Klockner Pentaplast Group
4. Bilcare Limited
5. Perlen Packaging AG
6. ACG Pharmapack Private Limited
7. UFlex Limited
8. Aluflexpack AG
9. Liveo Research GmbH
10. Rollprint Packaging Products, Inc.
11. R-Pharm Germany GmbH
12. Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
13. Zibo Zhongnan Pharmaceutical Packaging Materials Co., Ltd.
14. Nantong Huideseng Packaging Co., Ltd.
15. Shanghai Hongli Pharmaceutical Packaging Materials Co., Ltd.
16. Yangzhou Jerel Pharmaceutical New Material Co., Ltd.
17. Svam Toyal Packaging Industries Private Limited
18. Blisterpack Embalagens Ltda.
19. Blistal S.A.
20. Serpac Embalagens Farmaceuticas Ltda.
21. Dapack Embalagens Ltda.
22. Berkes S.A.
23. Blipack S.A.
24. Meprec S.A.S.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Unit-Dose and Adherence Packaging Demand
  • 4.2.2 Pharmaceutical Serialization and Traceability Requirements
  • 4.2.3 Expansion of Generic-Drug and Contract-Manufacturing Capacity
  • 4.2.4 High-Barrier Protection for Moisture-Sensitive Medicines
  • 4.2.5 Growth of Retail Pharmacy, Self-Medication, and Chronic-Therapy Volumes
  • 4.2.6 Localized Production and Near-Shoring of Pharmaceutical Packaging
• 4.3 Market Restraints
  • 4.3.1 Medical-Waste and Difficult-to-Recycle Multilayer Structures
  • 4.3.2 PVC, Aluminum, Resin, and Currency Volatility
  • 4.3.3 Limited Regional Capacity for Validated Specialty Barrier Films
  • 4.3.4 Qualification, Validation, and Tooling Costs for Small Batches
• 4.4 Impact of Macroeconomic Factors on the Market
• 4.5 Industry Value Chain Analysis
• 4.6 Regulatory Landscape
• 4.7 Technological Outlook
• 4.8 Porter's Five Forces Analysis
  • 4.8.1 Bargaining Power of Suppliers
  • 4.8.2 Bargaining Power of Buyers
  • 4.8.3 Threat of New Entrants
  • 4.8.4 Threat of Substitutes
  • 4.8.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Product Type
  • 5.1.1 Carded and Face-Seal Blisters
  • 5.1.2 Clamshell Blisters
  • 5.1.3 Trapped and Full-Card Blisters
  • 5.1.4 Child-Resistant and Senior-Friendly Blisters
  • 5.1.5 Other Product Types
• 5.2 By Material
  • 5.2.1 Plastic Films
  • 5.2.2 Aluminum Foil
  • 5.2.3 Paper and Paperboard
  • 5.2.4 Other Materials
• 5.3 By Technology
  • 5.3.1 Thermoforming
  • 5.3.2 Cold Forming
  • 5.3.3 Heat-Seal and Heat-Shrink
• 5.4 By Application
  • 5.4.1 Tablets
  • 5.4.2 Capsules
  • 5.4.3 Oral Thin Films and Lozenges
  • 5.4.4 Diagnostic Kits
  • 5.4.5 Other Applications
• 5.5 By End User
  • 5.5.1 Branded and Generic Pharmaceutical Manufacturers
  • 5.5.2 Contract Development and Manufacturing Organizations
  • 5.5.3 Contract Packaging Organizations
• 5.6 By Packaging Format
  • 5.6.1 Push-Through Blisters
  • 5.6.2 Peelable Blisters
  • 5.6.3 Alu-Alu Blisters
  • 5.6.4 PVC-PVDC Blisters
  • 5.6.5 PVC-PET and Polypropylene Blisters
• 5.7 By Geography
  • 5.7.1 Brazil
  • 5.7.2 Argentina
  • 5.7.3 Colombia
  • 5.7.4 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 Constantia Flexibles Group GmbH
  • 6.4.2 Tekni-Plex, Inc.
  • 6.4.3 Klockner Pentaplast Group
  • 6.4.4 Bilcare Limited
  • 6.4.5 Perlen Packaging AG
  • 6.4.6 ACG Pharmapack Private Limited
  • 6.4.7 UFlex Limited
  • 6.4.8 Aluflexpack AG
  • 6.4.9 Liveo Research GmbH
  • 6.4.10 Rollprint Packaging Products, Inc.
  • 6.4.11 R-Pharm Germany GmbH
  • 6.4.12 Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
  • 6.4.13 Zibo Zhongnan Pharmaceutical Packaging Materials Co., Ltd.
  • 6.4.14 Nantong Huideseng Packaging Co., Ltd.
  • 6.4.15 Shanghai Hongli Pharmaceutical Packaging Materials Co., Ltd.
  • 6.4.16 Yangzhou Jerel Pharmaceutical New Material Co., Ltd.
  • 6.4.17 Svam Toyal Packaging Industries Private Limited
  • 6.4.18 Blisterpack Embalagens Ltda.
  • 6.4.19 Blistal S.A.
  • 6.4.20 Serpac Embalagens Farmaceuticas Ltda.
  • 6.4.21 Dapack Embalagens Ltda.
  • 6.4.22 Berkes S.A.
  • 6.4.23 Blipack S.A.
  • 6.4.24 Meprec S.A.S.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment